Spots Global Cancer Trial Database for Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy
Official Title: See Detailed Description
Study ID: NCT00169572
Study Description
Brief Summary: This study was designed to assess the safety and efficacy of an investigational agent administered in addition to a standard anti-emetic regimen for the treatment of chemotherapy induced nausea and vomiting.
Detailed Description: Phase II Multicentre, Randomised, Double-Blind, Placebo and Active-Controlled, Dose-Ranging, Parallel Group Study of the Safety and Efficacy of The Oral Neurokinin-1 Receptor Antagonist, GW679769 in Combination with Ondansetron Hydrochloride and Dexamethasone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Subjects Receiving Highly Emetogenic Cisplatin-based Chemotherapy.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Capital Federal, Buenos Aires, Argentina
GSK Investigational Site, Ciudad Autonoma de Buenos Aires, , Argentina
GSK Investigational Site, Salzburg, , Austria
GSK Investigational Site, Vienna, , Austria
GSK Investigational Site, Vienna, , Austria
GSK Investigational Site, Edegem, , Belgium
GSK Investigational Site, Gent, , Belgium
GSK Investigational Site, Leuven, , Belgium
GSK Investigational Site, Liege, , Belgium
GSK Investigational Site, Santiago, Región Metro De Santiago, Chile
GSK Investigational Site, Santiago, Región Metro De Santiago, Chile
GSK Investigational Site, Zagreb, , Croatia
GSK Investigational Site, Hradec Kralove, , Czech Republic
GSK Investigational Site, Ostrava - Poruba, , Czech Republic
GSK Investigational Site, Praha 2, , Czech Republic
GSK Investigational Site, Praha 5, , Czech Republic
GSK Investigational Site, Praha 8, , Czech Republic
GSK Investigational Site, Shatin, N.T., , Hong Kong
GSK Investigational Site, Budapest, , Hungary
GSK Investigational Site, Székesfehérvár, , Hungary
GSK Investigational Site, Benevento, Campania, Italy
GSK Investigational Site, Napoli, Campania, Italy
GSK Investigational Site, Roma, Lazio, Italy
GSK Investigational Site, Roma, Lazio, Italy
GSK Investigational Site, Casalpusterlengo (LO), Lombardia, Italy
GSK Investigational Site, Sassari, Sardegna, Italy
GSK Investigational Site, Pisa, Toscana, Italy
GSK Investigational Site, Perugia, Umbria, Italy
GSK Investigational Site, Merida, Yucatán, Mexico
GSK Investigational Site, Durango, , Mexico
GSK Investigational Site, Amsterdam, , Netherlands
GSK Investigational Site, Amsterdam, , Netherlands
GSK Investigational Site, Arnhem, , Netherlands
GSK Investigational Site, Rotterdam, , Netherlands
GSK Investigational Site, Utrecht, , Netherlands
GSK Investigational Site, Karachi, , Pakistan
GSK Investigational Site, Lahore, , Pakistan
GSK Investigational Site, Callao, , Peru
GSK Investigational Site, Quezon City, , Philippines
GSK Investigational Site, Taft Avenue, Manila, , Philippines
GSK Investigational Site, Bydogoszcz, , Poland
GSK Investigational Site, Krakow, , Poland
GSK Investigational Site, Poznan, , Poland
GSK Investigational Site, Poznan, , Poland
GSK Investigational Site, Bucuresti, , Romania
GSK Investigational Site, Singapore, , Singapore
GSK Investigational Site, Kosice, , Slovakia
GSK Investigational Site, Nitra, , Slovakia
GSK Investigational Site, Taipei, , Taiwan
GSK Investigational Site, Taipei, , Taiwan
GSK Investigational Site, Tao Yuan County, , Taiwan
Contact Details
Name: GSK Clinical Trials, MD
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
